make notes based on uploaded pdf
| Compound | Details |
|---|---|
| Copper sulfate (blue vitriol, bluestone, nila tutia) | Blue crystals, freely soluble; caustic/astringent taste; most common poison |
| Copper subacetate (verdigris) | Blue-green compound; found on weathered brass/bronze/copper; used as fungicide |
| Copper carbonate | Blue-green; part of verdigris patina |
Note: Copper sulfate acts both as poison and antidote (historically used as antidote in phosphorus poisoning and wound debridement)
| System | Signs & Symptoms |
|---|---|
| GIT | Metallic taste, increased salivation (ptyalism), burning stomach pain, thirst, colicky abdominal pain, nausea, eructation, greenish-blue vomitus, hemorrhagic gastroenteritis |
| Renal | Oliguria, hematuria, hemoglobinuria, albuminuria, uremia |
| Hepatic | Jaundice, tender hepatomegaly, hepatic encephalopathy |
| MS | Cramps/spasms of legs, paralysis of limbs, rhabdomyolysis |
| CVS | Breathing difficulty, cold perspiration, methemoglobinemia, hypotension, tachycardia, circulatory collapse, shock |
| CNS | Frontal headache, lethargy, drowsiness, insensibility, irreversible coma, death |
G-6-PD deficient individuals are at increased risk of hematologic effects
| Copper subacetate | 15 g |
| Copper sulfate | 10β20 g (0.15β0.3 g/kg) |
| Fatal period | 18β24 hours (may extend to 1β3 days) |
| Step | Detail |
|---|---|
| No emetics | Vomiting occurs spontaneously in 5β10 min; emetics risk re-exposure of esophagus |
| Gastric lavage | 1% potassium ferrocyanide β forms insoluble cupric ferrocyanide; plain water if unavailable |
| Demulcents | Egg white or milk (form insoluble albuminate of copper); sucralfate for mucosal injury |
| Castor oil | Removes poison from intestines |
| Methemoglobinemia | Methylene blue 1β2 mg/kg of 1% solution IV over 5 min |
| Chelation (1st choice) | D-penicillamine (chelator of choice); alternatives: DMSA, DMPS (hydrophilic dithiol chelators β more efficient), EDTA, BAL |
| Pain | Morphine injection |
| Hypotension | Fluids, dopamine, noradrenaline |
| Severe cases | Hydrocortisone 50β100 mg IM TDS (for anorexia + hematuria; routine steroid use is doubtful) |
| Hemodialysis | Ineffective for copper removal; may be indicated for renal failure |
Tetrathiomolybdate β suggested chelating agent; enhances urinary excretion via increased molybdenum intake
make pathophysiology of acute myocardial infarction in flowchart from harrison only
ββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββ
β ATHEROSCLEROTIC CORONARY ARTERY DISEASE (CAD) β
β Lipid-rich core + thin fibrous cap = "Vulnerable Plaque" β
β (eccentric stenosis with scalloped/overhanging edges) β
ββββββββββββββββββββββββββββ¦ββββββββββββββββββββββββββββββββββββββββ
β
ββββββββββββββββββΌβββββββββββββββββ
βΌ βΌ βΌ
βββββββββββββββββ βββββββββββββββ ββββββββββββββββββββ
β PLAQUE FISSUREβ β PLAQUE β β PLAQUE EROSION β
β WITH β β FISSURE β β (β₯1/3 of all ACS)β
β INFLAMMATION β β WITHOUT β β β
β β β INFLAMMATIONβ β β
β β Effector T β β β β β
β cells (adaptiveβ β β β β
β immunity β β β β β
β dysregulation)β β β β β
βββββββββ¬ββββββββ ββββββββ¬βββββββ ββββββββββ¬ββββββββββ
ββββββββββββββββββΌββββββββββββββββββ
βΌ
ββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββ
β EXPOSURE OF THROMBOGENIC MATERIAL IN PLAQUE CORE β
β TO CIRCULATING BLOOD COMPONENTS β
ββββββββββββββββββββββββββββ¦ββββββββββββββββββββββββββββββββββββββββ
β
ββββββββββββββββββΌββββββββββββββββββ
βΌ βΌ βΌ
ββββββββββββββββ βββββββββββββββ βββββββββββββββββββ
β PLATELET β β FIBRIN β β VASOCONSTRICTIONβ
β AGGREGATION β β FORMATION β β (coronary spasm)β
ββββββββ¬ββββββββ ββββββββ¬βββββββ ββββββββββ¬βββββββββ
ββββββββββββββββββββΌββββββββββββββββββ
βΌ
ββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββ
β PLATELET-RICH ARTERIAL THROMBUS FORMATION β
β (arterial thrombi are white and platelet-rich due to β
β high shear in injured arteries) β
ββββββββββββββββββββββββββββ¦ββββββββββββββββββββββββββββββββββββββββ
β
βββββββββββββββββββ΄βββββββββββββββββββ
βΌ βΌ
βββββββββββββββββββββ ββββββββββββββββββββββ
β PARTIAL CORONARY β β COMPLETE CORONARY β
β OCCLUSION β β OCCLUSION β
β (non-occlusive β β (occlusive β
β thrombus) β β thrombus) β
ββββββββββ¬βββββββββββ βββββββββββ¬βββββββββββ
βΌ βΌ
βββββββββββββββββββββββ ββββββββββββββββββββββββββ
β NSTE-ACS β β STEMI β
β β’ Unstable Angina β β (ST-segment elevation β
β (no troponin rise)β β MI β transmural) β
β β’ NSTEMI β β β
β (troponin +ve, β β β
β subendocardial β β β
β necrosis) β β β
ββββββββββ¬βββββββββββββ ββββββββββββ¬ββββββββββββββ
ββββββββββββββββββββ¬βββββββββββββββββββ
βΌ
ββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββ
β IMBALANCE: MYOCARDIAL Oβ SUPPLY < DEMAND β
ββββββββββββββββββββββββββββ¦ββββββββββββββββββββββββββββββββββββββββ
βΌ
ββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββ
β MYOCARDIAL ISCHEMIA β
β β’ Lowered resting membrane potential β
β β’ Shortened action potential duration β
β β’ Voltage gradient between normal & ischemic zones β
β β’ "Currents of injury" β ST deviations on ECG β
ββββββββββββββββββββββββββββ¦ββββββββββββββββββββββββββββββββββββββββ
βΌ
ββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββ
β PROGRESSIVE CELL DEATH β
β (Irreversible necrosis) β
β Order of vulnerability: Erythrocytes β Subendocardium first β
β ("wavefront phenomenon" β inner to outer layers) β
ββββββββββββββββββββββββββββ¦ββββββββββββββββββββββββββββββββββββββββ
βΌ
βββββββββββββββββββ΄βββββββββββββββββββ
βΌ βΌ
βββββββββββββββββββββββ βββββββββββββββββββββββββββββ
β LV DYSFUNCTION β β NEUROHUMORAL ACTIVATION β
β β’ β Contractility β β β’ β Sympathetic tone β
β β’ Regional wall β β β’ β Catecholamines β
β motion abnorm. β β β’ β RAAS activation β
β β’ β LVEDP β β β’ β AVP (vasopressin) β
β β’ β Stroke volume β ββββββββββββββββ¦βββββββββββββ
β β’ β Cardiac output β β
ββββββββββββ¦βββββββββββ βΌ
β βββββββββββββββββββββββββββββββ
βΌ β Tachycardia, vasoconstrictionβ
βββββββββββββββββββββββββββββββ β NaβΊ/HβO retention β
β COMPLICATIONS β βββββββββββββββββββββββββββββββ
β β
β βββββββββββββββββββββββ β
β β ELECTRICAL β β
β β β’ VF/VT (most β β
β β common early β β
β β cause of death) β β
β β β’ Heart block β β
β β β’ Atrial fibrillationβ β
β βββββββββββββββββββββββ β
β β
β βββββββββββββββββββββββ β
β β MECHANICAL β β
β β β’ Cardiogenic shockβ β
β β β’ Acute MR (papillaryβ β
β β muscle rupture) β β
β β β’ VSD (septal β β
β β rupture) β β
β β β’ Free wall ruptureβ β
β β β’ LV aneurysm β β
β βββββββββββββββββββββββ β
β β
β βββββββββββββββββββββββ β
β β ISCHEMIC β β
β β β’ Extension of MI β β
β β β’ Recurrent β β
β β ischemia β β
β βββββββββββββββββββββββ β
βββββββββββββββββββββββββββββββ
| Step | Mechanism (Harrison's) |
|---|---|
| Vulnerable plaque | Lipid-rich core + thin fibrous cap; eccentric stenosis on angiography |
| Plaque disruption triggers | (1) Fissure with inflammation (β effector T cells), (2) Fissure without inflammation, (3) Erosion (β₯1/3 of cases) |
| Thrombus type | Platelet-rich (white) β due to high arterial shear forces |
| Partial occlusion β NSTE-ACS | Non-occlusive thrombus β UA (no necrosis) or NSTEMI (subendocardial necrosis, troponin +ve) |
| Complete occlusion β STEMI | Occlusive thrombus β transmural ischemia β full-thickness infarction |
| Ischemia β electrophysiology | β Resting membrane potential, β action potential duration β "currents of injury" β ST changes |
| STEMI ECG pattern | Transmural ischemia: ST vector directed outward β ST elevation in overlying leads; hyperacute T waves early |
| NSTEMI ECG pattern | Subendocardial: ST vector toward cavity β ST depression; ST elevation in aVR |
| Necrosis progression | Subendocardium most vulnerable (reduced coronary driving pressure + increased compressive forces) |
| Oβ demand-supply imbalance | Fixed epicardial obstruction + dynamic vasoconstriction/spasm amplifies ischemia |
Atherosclerotic Plaque Disruption
β
βββββββββββ΄βββββββββββ
β β
OCCLUSIVE NON-OCCLUSIVE
THROMBUS THROMBUS
β β
Transmural Subendocardial
Ischemia Ischemia
β β
ST ELEVATION ST Depression /
(STEMI) No ST change
β (NSTE-ACS)
Full-thickness β
Necrosis βββββ΄ββββ
No necrosis Necrosis
(Unstable (NSTEMI β
Angina) Troponin +ve)